Benjamin Philpot
Professor of neuroscience
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.